Provided by Tiger Fintech (Singapore) Pte. Ltd.

Root, Inc.

128.25
+0.45000.35%
Post-market: 128.24-0.0100-0.01%19:56 EDT
Volume:681.38K
Turnover:86.81M
Market Cap:1.97B
PE:40.58
High:128.82
Open:128.00
Low:124.00
Close:127.80
Loading ...

Stock Track | Root, Inc. Surges 5.77% Pre-market Following Stellar Q1 Earnings, Beating Expectations

Stock Track
·
08 May

Stock Track | Root, Inc. Soars 5.77% After Smashing Q1 Earnings Expectations

Stock Track
·
08 May

Stock Track | Root, Inc. Soars 5.77% After Smashing Q1 Earnings Expectations

Stock Track
·
08 May

Earnings Flash (ROOT) Root Q1 EPS $1.07

MT Newswires Live
·
08 May

Earnings Flash (ROOT) Root Q1 Revenue $349.4 Million Vs. FactSet Est. $318.9 Million

MT Newswires Live
·
08 May

Root Inc - Q1 Gross Premiums Written $410.8 Mln; Net Income $18.4 Mln

THOMSON REUTERS
·
08 May

Root Q1 GAAP EPS $1.07, Sales $349.40M Beat $322.66M Estimate

Benzinga
·
08 May

Root Inc expected to post earnings of 34 cents a share - Earnings Preview

Reuters
·
06 May

KBR, Hazer enter alliance agreement for licensing, commercialization

TIPRANKS
·
05 May

Why Alphabet's Investors Should Root for Its Breakup

Motley Fool
·
03 May

Why Root, Inc. (ROOT) Is Surging in 2025

Insider Monkey
·
03 May

New Philips Norelco Shaver i9000 Prestige Ultra Introduces the Brand's First "Root-Level" Shave, for Closest Shave Yet

PR Newswire
·
01 May

Root, Inc. (ROOT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks
·
30 Apr

Press Release: Lithium Royalty Corp. Announces First Quarter 2025 Results

Dow Jones
·
30 Apr

Experian Adds Root Insurance to Its Auto Insurance Portfolio

Business Wire
·
30 Apr

Root Is Maintained at Outperform by Keefe, Bruyette & Woods

Dow Jones
·
22 Apr

Root price target raised to $150 from $90 at Keefe Bruyette

TIPRANKS
·
22 Apr

Even Short Recessions Hurt. Don't Root for One. -- Barrons.com

Dow Jones
·
22 Apr

Heritage Insurance (HRTG) Moves 7.4% Higher: Will This Strength Last?

Zacks
·
15 Apr

Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B

Business Wire
·
15 Apr